{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CHM.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CHM.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CHM.AU\",,,,,undefined,":{"symbol":"CHM.AU","market":"AU","secType":"STK","nameCN":"CHIMERIC THERAPEUTICS LTD","latestPrice":0.005,"timestamp":1744870320000,"preClose":0.005,"halted":0,"volume":2439197,"delay":0,"nameEN":"CHIMERIC THERAPEUTICS LTD","floatShares":1285276375,"shares":1620149846,"eps":-0.019396,"marketStatus":"Market Closed","change":0,"latestTime":"04-17 16:12:00 AEST","open":0.005,"high":0.005,"low":0.004,"amount":11672,"amplitude":0.2,"askPrice":0.006,"askSize":7030259,"bidPrice":0.004,"bidSize":12727089,"shortable":3,"etf":0,"ttmEps":-0.019396,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1745280000000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.005,"openAndCloseTimeList":[[1744848000000,1744869600000]],"volumeRatio":1.4474503432985888,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CHM.AU\",,,,,undefined,":{"symbol":"CHM.AU","floatShares":1285276375,"roa":"-48.71%","roe":"-180.09%","lyrEps":-0.018011,"volumeRatio":1.4474503432985888,"shares":1620149846,"dividePrice":0,"high":0.005,"amplitude":0.2,"preClose":0.005,"low":0.004,"week52Low":0.004,"pbRate":"1.36","psRate":"3.97","week52High":0.034,"institutionHeld":0,"latestPrice":0.005,"committee":0.28834,"eps":-0.019396,"divideRate":0,"volume":2439197,"delay":0,"ttmEps":-0.019396,"open":0.005,"prevYearClose":0.007,"prevWeekClose":0.005,"prevMonthClose":0.005,"prevQuarterClose":0.005,"fiveDayClose":0.005,"twentyDayClose":0.005,"sixtyDayClose":0.006},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CHM.AU\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CHM.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2524444680","title":"Chimeric Therapeutics Ltd-Entitlement Offer Closing Date Extended to 22 April 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2524444680","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524444680?lang=en_us&edition=fundamental","pubTime":"2025-04-03 05:25","pubTimestamp":1743629135,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250402:nTUE1BFFMB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","CHM.AU"],"gpt_icon":0},{"id":"2522051059","title":"Chimeric Therapeutics Secures US Patent Allowance for Gastrointestinal Cancer Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2522051059","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522051059?lang=en_us&edition=fundamental","pubTime":"2025-03-25 11:25","pubTimestamp":1742873144,"startTime":"0","endTime":"0","summary":"Chimeric Therapeutics  secured a US patent allowance for its CHM CDH17 chimeric antigen receptor technology, a CAR-T therapy targeting gastrointestinal cancers, according to a Tuesday filing with the Australian bourse.The patent application is for compositions and methods for retrieving tumor-related antibodies and antigens, the filing said.The patent allowance is expected to provide patent protection until at least 2039.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","CHM.AU","BK4139","BK7067"],"gpt_icon":0},{"id":"2522312035","title":"BRIEF-Chimeric Therapeutics Says US Patent Allowed For CHM CDH17 Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2522312035","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522312035?lang=en_us&edition=fundamental","pubTime":"2025-03-25 08:55","pubTimestamp":1742864131,"startTime":"0","endTime":"0","summary":"BRIEF-Chimeric Therapeutics Says US Patent Allowed For CHM CDH17 TechnologyMarch 25 (Reuters) - Chimeric Therapeutics Ltd CHM.AX:US PATENT ALLOWED FOR CHM CDH17 TECHNOLOGYFurther company coverage: CHM.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nFWN3Q7183:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHM.AU","BK7067"],"gpt_icon":0},{"id":"2522086715","title":"Chimeric Therapeutics Ltd-Entitlement Offer Documents","url":"https://stock-news.laohu8.com/highlight/detail?id=2522086715","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522086715?lang=en_us&edition=fundamental","pubTime":"2025-03-25 06:09","pubTimestamp":1742854157,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nTUE3DSSWT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CHM.AU","BK7067"],"gpt_icon":0}],"pageSize":4,"totalPage":8,"pageCount":1,"totalSize":29,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CHM.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CHM.AU\",market:\"AU\",,,undefined,":[]}}